Copyright Reports & Markets. All rights reserved.

Global Diphtheria, Pertussis, and Tetanus Vaccine Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Diphtheria, Pertussis, and Tetanus Vaccine

      • 1.1 Definition of Diphtheria, Pertussis, and Tetanus Vaccine
      • 1.2 Diphtheria, Pertussis, and Tetanus Vaccine Segment By product type
        • 1.2.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production Growth Rate Comparison By product type (2014-2025)
        • 1.2.2 DTaP
        • 1.2.3 Td
        • 1.2.4 Tdap
      • 1.3 Diphtheria, Pertussis, and Tetanus Vaccine Segment by Applications
        • 1.3.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Vaccination Centers
      • 1.4 Global Diphtheria, Pertussis, and Tetanus Vaccine Overall Market
        • 1.4.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue (2014-2025)
        • 1.4.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Production (2014-2025)
        • 1.4.3 North America Diphtheria, Pertussis, and Tetanus Vaccine Status and Prospect (2014-2025)
        • 1.4.4 Europe Diphtheria, Pertussis, and Tetanus Vaccine Status and Prospect (2014-2025)
        • 1.4.5 China Diphtheria, Pertussis, and Tetanus Vaccine Status and Prospect (2014-2025)
        • 1.4.6 Japan Diphtheria, Pertussis, and Tetanus Vaccine Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Status and Prospect (2014-2025)
        • 1.4.8 India Diphtheria, Pertussis, and Tetanus Vaccine Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Diphtheria, Pertussis, and Tetanus Vaccine
      • 2.3 Manufacturing Process Analysis of Diphtheria, Pertussis, and Tetanus Vaccine
      • 2.4 Industry Chain Structure of Diphtheria, Pertussis, and Tetanus Vaccine

      3 Development and Manufacturing Plants Analysis of Diphtheria, Pertussis, and Tetanus Vaccine

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Diphtheria, Pertussis, and Tetanus Vaccine
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Diphtheria, Pertussis, and Tetanus Vaccine Production and Capacity Analysis
      • 4.2 Diphtheria, Pertussis, and Tetanus Vaccine Revenue Analysis
      • 4.3 Diphtheria, Pertussis, and Tetanus Vaccine Price Analysis
      • 4.4 Market Concentration Degree

      5 Diphtheria, Pertussis, and Tetanus Vaccine Regional Market Analysis

      • 5.1 Diphtheria, Pertussis, and Tetanus Vaccine Production by Regions
        • 5.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Regions
        • 5.1.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Regions
      • 5.2 Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Regions
      • 5.3 North America Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis
        • 5.3.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Production
        • 5.3.2 North America Diphtheria, Pertussis, and Tetanus Vaccine Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Diphtheria, Pertussis, and Tetanus Vaccine Import and Export
      • 5.4 Europe Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis
        • 5.4.1 Europe Diphtheria, Pertussis, and Tetanus Vaccine Production
        • 5.4.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Diphtheria, Pertussis, and Tetanus Vaccine Import and Export
      • 5.5 China Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis
        • 5.5.1 China Diphtheria, Pertussis, and Tetanus Vaccine Production
        • 5.5.2 China Diphtheria, Pertussis, and Tetanus Vaccine Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Diphtheria, Pertussis, and Tetanus Vaccine Import and Export
      • 5.6 Japan Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis
        • 5.6.1 Japan Diphtheria, Pertussis, and Tetanus Vaccine Production
        • 5.6.2 Japan Diphtheria, Pertussis, and Tetanus Vaccine Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Diphtheria, Pertussis, and Tetanus Vaccine Import and Export
      • 5.7 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis
        • 5.7.1 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Production
        • 5.7.2 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Import and Export
      • 5.8 India Diphtheria, Pertussis, and Tetanus Vaccine Market Analysis
        • 5.8.1 India Diphtheria, Pertussis, and Tetanus Vaccine Production
        • 5.8.2 India Diphtheria, Pertussis, and Tetanus Vaccine Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Diphtheria, Pertussis, and Tetanus Vaccine Import and Export

      6 Diphtheria, Pertussis, and Tetanus Vaccine Segment Market Analysis (by Type)

      • 6.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Production by Type
      • 6.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Revenue by Type
      • 6.3 Diphtheria, Pertussis, and Tetanus Vaccine Price by Type

      7 Diphtheria, Pertussis, and Tetanus Vaccine Segment Market Analysis (by Application)

      • 7.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption by Application
      • 7.2 Global Diphtheria, Pertussis, and Tetanus Vaccine Consumption Market Share by Application (2014-2019)

      8 Diphtheria, Pertussis, and Tetanus Vaccine Major Manufacturers Analysis

      • 8.1 Johnson & Johnson
        • 8.1.1 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
        • 8.1.2 Johnson & Johnson Product Introduction, Application and Specification
        • 8.1.3 Johnson & Johnson Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 GlaxoSmithKline
        • 8.2.1 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
        • 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.2.3 GlaxoSmithKline Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Sanofi
        • 8.3.1 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
        • 8.3.2 Sanofi Product Introduction, Application and Specification
        • 8.3.3 Sanofi Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Lanzhou Institute of Biological
        • 8.4.1 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
        • 8.4.2 Lanzhou Institute of Biological Product Introduction, Application and Specification
        • 8.4.3 Lanzhou Institute of Biological Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Merck
        • 8.5.1 Merck Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
        • 8.5.2 Merck Product Introduction, Application and Specification
        • 8.5.3 Merck Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Novartis
        • 8.6.1 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
        • 8.6.2 Novartis Product Introduction, Application and Specification
        • 8.6.3 Novartis Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 AstraZeneca
        • 8.7.1 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
        • 8.7.2 AstraZeneca Product Introduction, Application and Specification
        • 8.7.3 AstraZeneca Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Emergent
        • 8.8.1 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
        • 8.8.2 Emergent Product Introduction, Application and Specification
        • 8.8.3 Emergent Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Astellas
        • 8.9.1 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Production Sites and Area Served
        • 8.9.2 Astellas Product Introduction, Application and Specification
        • 8.9.3 Astellas Diphtheria, Pertussis, and Tetanus Vaccine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served

      9 Development Trend of Analysis of Diphtheria, Pertussis, and Tetanus Vaccine Market

      • 9.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Trend Analysis
        • 9.1.1 Global Diphtheria, Pertussis, and Tetanus Vaccine Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Diphtheria, Pertussis, and Tetanus Vaccine Regional Market Trend
        • 9.2.1 North America Diphtheria, Pertussis, and Tetanus Vaccine Forecast 2019-2025
        • 9.2.2 Europe Diphtheria, Pertussis, and Tetanus Vaccine Forecast 2019-2025
        • 9.2.3 China Diphtheria, Pertussis, and Tetanus Vaccine Forecast 2019-2025
        • 9.2.4 Japan Diphtheria, Pertussis, and Tetanus Vaccine Forecast 2019-2025
        • 9.2.5 Southeast Asia Diphtheria, Pertussis, and Tetanus Vaccine Forecast 2019-2025
        • 9.2.6 India Diphtheria, Pertussis, and Tetanus Vaccine Forecast 2019-2025
      • 9.3 Diphtheria, Pertussis, and Tetanus Vaccine Market Trend (Product Type)
      • 9.4 Diphtheria, Pertussis, and Tetanus Vaccine Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Diphtheria, Pertussis, and Tetanus Vaccine Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Diphtheria, pertussis, and tetanus (DPT) vaccine is administered for three infectious diseases in humans-diphtheria, tetanus, and pertussis. They are administered either in childhood or middle age to produce the acquired immunity against diphtheria, pertussis, and tetanus.

        The global Diphtheria, Pertussis, and Tetanus Vaccine market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Diphtheria, Pertussis, and Tetanus Vaccine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diphtheria, Pertussis, and Tetanus Vaccine market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Diphtheria, Pertussis, and Tetanus Vaccine in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Diphtheria, Pertussis, and Tetanus Vaccine manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Johnson & Johnson
        GlaxoSmithKline
        Sanofi
        Lanzhou Institute of Biological
        Merck
        Novartis
        AstraZeneca
        Emergent
        Astellas

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        By product type
        DTaP
        Td
        Tdap
        By vaccine type
        Whole-Cell Vaccine
        Acellular Vaccine
        By age
        Adult
        Pediatric

        Segment by Application
        Hospitals
        Clinics
        Vaccination Centers

        Buy now